MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
47 hedge funds and large institutions have $29.9M invested in Merrimack Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 37 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-3
Holders Change %
-6%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
6
Reduced
37
Closed
7
Calls
$214K
Puts
$114K
Net Calls
+$100K
Net Calls Change
-$132K
Top Buyers
| 1 |
SC
Sepio Capital
Salt Lake City,
Utah
|
+$1.03M |
| 2 |
LA
LVW Advisors
Pittsford,
New York
|
+$308K |
| 3 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$220K |
| 4 |
CCIA
Campbell & Co Investment Adviser
Baltimore,
Maryland
|
+$111K |
| 5 |
Morgan Stanley
New York
|
+$108K |
